Table 3.
MULTIVARIABLE HR (95% CI) |
||
---|---|---|
Age in years | 1.02 (0.99–1.05) | p=0.11 |
| ||
Stage | p=0.004* | |
1b1 | 1.00 | |
1b2 | 3.90 (1.76–8.64) | |
2a1 | 1.31 (0.18–9.75) | |
| ||
LVSI | p=0.045* | |
No | 1.00 | |
Yes | 1.98 (1.01–3.91) | |
unknown | 0.82 (0.35–1.92) | |
| ||
Grade | p=0.30 | |
1 | 1.00 | |
2 | 3.03 (0.68–13.42) | |
3 | 2.22 (0.42–11.62) | |
| ||
Adjuvant therapy | p=0.67 | |
No | 1.00 | |
Yes | 1.18 (0.56–2.46) | |
| ||
Diameter | p<0.001* | |
≤ 20 mm | 1.00 | |
> 20 mm | 2.08 (1.07–4.03) | |
| ||
Surgical Approach | p=0.054 | |
Open | 1.00 | |
Others | 1.88 (0.99–3.57) | |
| ||
Histotype | p=0.008* | |
Squamous | 1.00 | |
Adenocarcinoma | 1.42 (0.69–2.92) | |
Other | 3.19 (1.35–7.55) | |
| ||
Number of radical hysterectomies per year | p=0.27 | |
<7 | 1.00 | |
7–17 | 0.43 (0.15–1.21) | |
>17 | 0.55 (0.20–1.48) |
p<0.05